RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ZOLA P
Collezione ASL Biella

Items : 9

Vitamin D Supplementation in Neonatal and Infant MIS-C Following COVID-19 Infection. in International journal of molecular sciences / Int J Mol Sci. 2024 Mar 27;25(7):3712. doi: 10.3390/ijms25073712.

2024
ASL Biella

Rizzi M; Avellis V; Messina A; Germano C; Tavella E; Dodaro V; Vitale R; Revelli A; Zola P; Picone S; Paolillo PM; Mondì V; Masturzo B; Manzoni P; Sainaghi PP;

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. in British journal of cancer / Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9.

2023
AOU Città della Salute di Torino
ASL Biella

Poveda A; Tsibulak I; Wimberger P; Heinzelmann-Schwarz V; Westermann A; Aglietta M; Arcangeli V; Zamagni C; Bologna A; Benedetti Panici P; Zola P; De Giorgi U; DeCensi A; Tognon G; Rubio-Pérez MJ; Pardo B; Romeo M; Tasca G; Funari G; Iglesias M; Biagioli E; Barretina-Ginesta MP; Deryal M; Mirza MR; Fossati R; Herbertson R; Riniker S; Nyvang GB; Chekerov R; et alii...

Effectiveness of Intensive Versus Minimalist Follow-Up Regimen on Survival in Patients With Endometrial Cancer (TOTEM Study): A Randomized, Pragmatic, Parallel Group, Multicenter Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Nov 20;40(33):3817-3827. doi: 10.1200/JCO.22.00471. Epub 2022 Jul 20.

2022
ASL Città di Torino
ASL Torino 3
ASL Biella
ASL Cuneo 2
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AO Ordine Mauriziano

Ferrero A; Piovano E; Bertetto O; Peirano E; Landoni F; Sartori E; Narducci F; Castiglione A; Pagano E; Di Cuonzo D; Fuso L; Zola P; Ciccone G;

Use of Positron Emission Tomography for Pregnancy-Associated Cancer Assessment: A Review. in Journal of clinical medicine / J Clin Med. 2022 Jul 1;11(13):3820. doi: 10.3390/jcm11133820.

2022
ASL Biella
AOU Città della Salute di Torino

Zola P; Masturzo B; Germano C; Giunta FP; Laudani ME; Parpinel G;

Fetal Brain Damage during Maternal COVID-19: Emerging Hypothesis, Mechanism, and Possible Mitigation through Maternal-Targeted Nutritional Supplementation. in Nutrients / Nutrients. 2022 Aug 12;14(16):3303. doi: 10.3390/nu14163303.

2022
ASL Biella
AOU Città della Salute di Torino

Germano C; Messina A; Tavella E; Masturzo B; Manzoni P; Zola P; Revelli A; Attini R; Barboni M; Avellis V; Vitale R;

Intensive versus minimalist followup in patients treated for endometrial cancer: A multicentric randomized controlled trial (The TOTEM study-NCT00916708) in Journal of Clinical Oncology

2021
ASL Biella
ASL Cuneo 1
AOU Città della Salute di Torino

Zavallone L; Berretta R; Loda S; Ferrero A; Chiudinelli F; Comerci G; Fambrini M; Greggi S; Adorni M; Busato E; Marinaccio M; Menada MV; Mandato VD; Perrone AM; Di Cuonzo D; Peirano E; Fuso L; Piovano E; Ciccone G; Zola P;

Does intensive follow-up improve overall survivalin endometrial cancer patients? results from the totem randomized controlled trial in International Journal of Gynecological Cancer

2021
AOU Città della Salute di Torino
ASL Biella

Zola P; Ciccone G; Angioli R; Terranova C; Piovano E; Fuso L; Di Cuonzo D; Peirano E; Perrone AM; Mandato VD; Zavallone L; Chiudinelli F; Berretta R; Loda S; Greggi S; Adorni M; Busato E; Comerci G; Fambrini M; Ferrero A;

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1998;41(4):333-8. doi: 10.1007/s002800050747.

1998
AOU San Luigi di Orbassano
ASL Biella
ASL Cuneo 2

Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G;

Prognostic factors in metastatic breast cancer patients obtaining objective response or disease stabilization after first-line chemotherapy with epirubicin. Evidence for a positive effect of maintenance hormonal therapy on overall survival in Anticancer Research

1997
ASL Cuneo 1
ASL Biella
ASL Cuneo 2
AO Cuneo

Berruti A; Zola P; Buniva T; Baú MG; Farris A; Sarobba MG; Bottin A; Tampellini M; Durando A; Destefanis M; Monzeglio C; Moro G; Sussio M; Perroni D; Dogliotti L;